reuptake inhibitor

Efficacy of Add-on Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder: Three Case Reports.

Published June 1, 2013

Efficacy of Add-On Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder: Three Case Reports.

Prim Care Companion CNS Disord. 2013; 15(1):
Rapinesi C, Kotzalidis GD, Serata D, Casale AD, Bersani FS, Solfanelli A, Scatena P, Raccah… Continue reading →

Diagnosis of Coronary Arteries Stenosis Using Data Mining.

Published May 30, 2013

Diagnosis of Coronary Arteries Stenosis Using Data Mining.

J Med Signals Sens. 2012 7; 2(3): 153-159
Alizadehsani R, Habibi J, Bahadorian B, Mashayekhi H, Ghandeharioun A, Boghrati R, Sani ZA

Cardiovascular diseases are one of the most common diseases… Continue reading →

Serotonin Reuptake Inhibitor Use, Depression, and Long-Term Outcomes After an Acute Coronary Syndrome: A Prospective Cohort Study.

Published May 25, 2013

Serotonin Reuptake Inhibitor Use, Depression, and Long-Term Outcomes After an Acute Coronary Syndrome: A Prospective Cohort Study.

JAMA Intern Med. 2013 May 13; 1-2
Rieckmann N, Kronish IM, Shapiro PA, Whang W, Davidson KW

HubMed – depression

Rapid… Continue reading →

Association Among Stress, Salivary Cortisol Levels, and Chronic Periodontitis.

Published May 17, 2013

Association among stress, salivary cortisol levels, and chronic periodontitis.

J Periodontal Implant Sci. 2013 Apr; 43(2): 96-100
Refulio Z, Rocafuerte M, de la Rosa M, Mendoza G, Chambrone L

Chronic periodontitis (CP) seems to be associated with stress and… Continue reading →

Interplay Between Pro-Inflammatory Cytokines and Growth Factors in Depressive Illnesses.

Published May 16, 2013

Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses.

Front Cell Neurosci. 2013; 7: 68
Audet MC, Anisman H

The development of depressive disorders had long been attributed to monoamine variations, and pharmacological treatment strategies likewise focused on… Continue reading →

Amphetamine Elicits Opposing Actions on Readily Releasable and Reserve Pools for Dopamine.

Published May 15, 2013

Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.

PLoS One. 2013; 8(5): e60763
Covey DP, Juliano SA, Garris PA

Amphetamine, a highly addictive drug with therapeutic efficacy, exerts paradoxical effects on the fundamental communication modes… Continue reading →

Changes in Capacity to Consent Over Time in Patients Involved in Psychiatric Research.

Published May 11, 2013

Changes in capacity to consent over time in patients involved in psychiatric research.

Br J Psychiatry. 2013 May 9;
Palmer BW, Savla GN, Roesch SC, Jeste DV

BACKGROUND: Informed consent is a key element of ethical clinical research. Patients… Continue reading →

How Effective Is Therapy for Depression?

Published May 11, 2013

by benchilada

Question by Gianna: How effective is therapy for depression?
Did you get “better” from therapy? Were you able to get over any emotional baggage you had?

I just need some insight.

Thank you.

Best answer:

Answer by petrof_skinsky… Continue reading →

Effect of Ultrasonic Irradiation on the Development of Symptoms of Depression and Anxiety in Rats.

Published May 10, 2013

Effect of ultrasonic irradiation on the development of symptoms of depression and anxiety in rats.

Bull Exp Biol Med. 2013 Mar; 154(6): 740-3
Morozova AY, Zubkov EA, Storozheva ZI, Kekelidze ZI, Chekhonin VP

Behavioral reactions of rats were studied… Continue reading →

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition.

Published May 9, 2013

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition.

PLoS One. 2013; 8(4): e62564
Wei SJ, Joseph T, Sim AY, Yurlova L, Zolghadr K, Lane D, Verma C, Ghadessy F

HDM2 binds to the p53 tumour suppressor and… Continue reading →